SOPHiA GENETICS SA Long Term Debt 2020-2024 | SOPH

SOPHiA GENETICS SA long term debt from 2020 to 2024. Long term debt can be defined as the sum of all long term debt fields.
SOPHiA GENETICS SA Annual Long Term Debt
(Millions of US $)
2023 $
2022 $
2021 $
2020 $0
2019 $2
SOPHiA GENETICS SA Quarterly Long Term Debt
(Millions of US $)
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31 $0
2020-09-30
2020-06-30
2020-03-31
2019-12-31 $2
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.305B $0.062B
SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $35.257B 19.36
Tempus AI (TEM) United States $5.669B 0.00
Hims & Hers Health (HIMS) United States $4.401B 0.00
Inspire Medical Systems (INSP) United States $3.980B 0.00
Axonics (AXNX) United States $3.445B 0.00
Olink Holding AB (publ) (OLK) Sweden $3.202B 0.00
IRhythm Technologies (IRTC) United States $3.010B 0.00
Azenta (AZTA) United States $2.800B 157.42
Enovis (ENOV) United States $2.438B 18.07
10x Genomics (TXG) United States $2.234B 0.00
Privia Health (PRVA) United States $2.022B 113.00
Schrodinger (SDGR) United States $1.461B 0.00
Omnicell (OMCL) United States $1.229B 42.48
Phreesia (PHR) United States $1.177B 0.00
Standard BioTools (LAB) United States $0.682B 0.00
Definitive Healthcare (DH) United States $0.631B 0.00
Clover Health Investments (CLOV) United States $0.621B 0.00
Fulgent Genetics (FLGT) United States $0.596B 0.00
Health Catalyst (HCAT) United States $0.365B 0.00
Talkspace (TALK) United States $0.365B 0.00
Pulmonx (LUNG) United States $0.245B 0.00
Butterfly Network (BFLY) United States $0.209B 0.00
Outset Medical (OM) United States $0.199B 0.00
TruBridge (TBRG) United States $0.168B 9.02
P3 Health Partners (PIII) United States $0.157B 0.00
American Well (AMWL) United States $0.089B 0.00
111 (YI) China $0.088B 0.00
EUDA Health Holdings (EUDA) Singapore $0.080B 0.00
SHL Telemedicine (SHLT) Israel $0.075B 0.00
HeartBeam (BEAT) United States $0.071B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
MSP Recovery (LIFW) United States $0.057B 0.00
Augmedix (AUGX) United States $0.049B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.048B 0.00
Zepp Health (ZEPP) China $0.039B 0.00
CareCloud (CCLD) United States $0.032B 0.00
Streamline Health Solutions (STRM) United States $0.031B 0.00
Movano (MOVE) United States $0.031B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Syra Health (SYRA) United States $0.008B 0.00
Biotricity (BTCY) United States $0.007B 0.00
Transgenomic (PRPO) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.003B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00